🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective, single-center phase 1 clinical study aimed at determ...
Status
Completed
Location
Froedtert Hospital & the Medical College of Wisconsin
Start Date
2019-05-24
Trial ID
NCT03848754
This phase III trial compares standard chemotherapy to therapy with liposom...
Status
Recruiting
Location
Children's Hospital of Alabama
Start Date
2020-07-21
Trial ID
NCT04293562
Treatments Being Tested
During the last fifteen years, the landscape of AML diagnosis and therapeut...
Status
Recruiting
Location
Chu Amiens
Start Date
2022-04-14
Trial ID
NCT04777916
Acute myeloid leukemia (AML) is a neoplasm of immature hematopoietic cells ...
Status
Completed
Location
Hospital Germans Trias i Pujol
Start Date
2009-10
Trial ID
NCT01698879
Treatments Being Tested
Gemtuzumab Ozogamicin/Mylotarg® (GO) is a conjugate of a derivative of cali...
Status
Unknown
Location
C.H.U. d'Amiens - Hôpital Sud
Start Date
2017-11-01
Trial ID
NCT03287128
Treatments Being Tested
GO-A-HAM: Gemtuzumab Ozogamicin 3g/m² day 1 Cytarabine 3g/m² bid days 1-3 ...
Status
Completed
Location
Department of Hematology / Oncology, University Hospital of Innsbruck
Start Date
2004-06
Trial ID
NCT00143975
Treatments Being Tested
The purpose of the study is to determine the safety of combining the drugs ...
Status
Recruiting
Location
Moffitt Cancer Center
Start Date
2023-02-16
Trial ID
NCT05558124
Treatments Being Tested
This phase II trial studies the side effects and how well liposome-encapsul...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2018-11-07
Trial ID
NCT03672539
Treatments Being Tested
The main objective of this study is to compare conventional chemotherapy: d...
Status
Completed
Location
CH
Start Date
2007-12
Trial ID
NCT00927498
This phase I/II trial studies the side effects and best dosing frequency of...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2018-09-14
Trial ID
NCT03531918